Valuation: Amedica Corporation

Market Cap 1.05Cr 90.38L 84.83L 77.48L 1.46Cr 100.43Cr 1.47Cr 10Cr 3.89Cr 51Cr 3.95Cr 3.87Cr 167.82Cr P/E 2026 *
-0.86x
P/E 2027 * -1.22x
Enterprise Value 1.05Cr 90.38L 84.83L 77.48L 1.46Cr 100.43Cr 1.47Cr 10Cr 3.89Cr 51Cr 3.95Cr 3.87Cr 167.82Cr EV / Sales 2026 *
3.56x
EV / Sales 2027 * 1.99x
Free-Float
77.28%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-6.84%+27.74% - - 1.05Cr
-0.28%-3.03%-16.40%+18.54% 13TCr
-0.23%+0.23%-22.39%-0.19% 1.22TCr
-0.45%-4.74%+92.53%+144.41% 1.06TCr
+2.13%-4.21%-51.63%-68.92% 420.7Cr
+0.57%+4.02%-22.01%+58.76% 277.2Cr
+1.20%+0.18%-32.64%-71.33% 178.67Cr
+1.12%-0.84%-23.32%-12.99% 165.73Cr
+0.47%-3.59%-36.96%-38.68% 158.53Cr
Average -0.26%-0.58%-14.10%+3.70% 2.02TCr
Weighted average by Cap. -0.17%-2.62%-11.13%+21.95%

Financials

2026 *2027 *
Net sales 29.55L 25.36L 23.81L 21.74L 41.03L 28Cr 41.23L 2.82Cr 1.09Cr 14Cr 1.11Cr 1.09Cr 47Cr 53.01L 45.5L 42.7L 39L 73.61L 51Cr 73.96L 5.05Cr 1.96Cr 26Cr 1.99Cr 1.95Cr 84Cr
Net income -1.24Cr -1.06Cr -99.8L -91.15L -1.72Cr -118.15Cr -1.73Cr -12Cr -4.58Cr -60Cr -4.65Cr -4.55Cr -197.43Cr -1.13Cr -96.99L -91.04L -83.15L -1.57Cr -107.78Cr -1.58Cr -11Cr -4.18Cr -54Cr -4.24Cr -4.15Cr -180.1Cr
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-